Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Karl Swedberg

Senior Professor

Karl Swedberg
Senior Professor
karl.swedberg@gu.se

Room number: 1319
Postal Address: SU Sahlgrenska, 41345 Göteborg
Visiting Address: Wallenberglab/su , Göteborg


Institute of Medicine (More Information)
Box 428
405 30 Göteborg
www.medicine.gu.se
medicin@gu.se
Fax: +46 31823925
Visiting Address: Medicinaregatan 3, plan 5 , 413 90 Göteborg

About Karl Swedberg

Karl Swedberg, MD, PhD, FESC, is Senior Professor of Cardiology and Care Science, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden. He is a Scientific Advisor to the University of Gothenburg Centre for Person Centred Care (GPCC).

He was the first to report on survival benefits of a beta-blocker (1979), an ACE-inhibitor (1987), an angiotensinreceptor blocker (2003) and recently an ARNI (angiotensin receptor antagonist and neprilysin inhibitor 2014) in chronic heart failure. He has published widely in international journals with more than 600 publications in peer-reviewed journals, 340 original research papers and > 65000 citations.

He was Chairman of the Task Force on the Diagnosis and Treatment of Chronic Heart Failure that updated the ESC Guidelines 2005. He has participated in Steering Committees in numerous outcome trials in myocardial infarction and heart failure.

Rewards and distinctions

  • Recipient of the 2004 Kaufman Award of heart failure research from Cleveland Clinics, USA.
  • Awarded European Society of Cardiology (ESC) Gold medal 2007 for outstanding contributions to the cardiovascular field.
  • He gave the Paul Dudley White international lecture, AHA annual meeting in Orlando 2009.
  • "Lifetime Achievement Award" from Heart Failure Association (HFA) of ESC in 2016.
  • Member of the Editorial Board of several international journals.
  • 2005-2009 he served as Editor-in-Chief of the European Journal of Heart Failure.
  • He is Associate Editor in European Heart Journal since 2012.
  • Among Highly cited 2017-2019 https://publons.com/researcher/2889721/karl-swedberg/

 

Latest publications

Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
Nadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, Michel Komajda, Karl Swedberg et al.
ESC heart failure, Journal article 2019
Journal article

Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
Kieran F Docherty, Li Shen, Davide Castagno, Mark C Petrie, William T Abraham et al.
European journal of heart failure, Journal article 2019
Journal article

Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, Ross T Campbell, Li Shen et al.
Circulation. Heart failure, Journal article 2019
Journal article

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
Scott D Solomon, Muthiah Vaduganathan, Brian L Claggett, Milton Packer, Michael Zile et al.
Circulation, Journal article 2019
Journal article

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
Peder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, Milton Packer, Akshay S Desai et al.
Journal of the American College of Cardiology, Journal article 2019
Journal article

Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction PARADIGM-HF
S. Selvaraj, B. Claggett, A. Pozzi, J. J. V. McMurray, P. S. Jhund et al.
Circulation, Journal article 2019
Journal article

Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
L. Shen, R. Rorth, D. Cosmi, S. L. Kristensen, M. C. Petrie et al.
European Journal of Heart Failure, Journal article 2019
Journal article

Showing 1 - 10 of 429

2019

Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
Nadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, Michel Komajda, Karl Swedberg et al.
ESC heart failure, Journal article 2019
Journal article

Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
Kieran F Docherty, Li Shen, Davide Castagno, Mark C Petrie, William T Abraham et al.
European journal of heart failure, Journal article 2019
Journal article

Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, Ross T Campbell, Li Shen et al.
Circulation. Heart failure, Journal article 2019
Journal article

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
Scott D Solomon, Muthiah Vaduganathan, Brian L Claggett, Milton Packer, Michael Zile et al.
Circulation, Journal article 2019
Journal article

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
Peder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, Milton Packer, Akshay S Desai et al.
Journal of the American College of Cardiology, Journal article 2019
Journal article

Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction PARADIGM-HF
S. Selvaraj, B. Claggett, A. Pozzi, J. J. V. McMurray, P. S. Jhund et al.
Circulation, Journal article 2019
Journal article

Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
L. Shen, R. Rorth, D. Cosmi, S. L. Kristensen, M. C. Petrie et al.
European Journal of Heart Failure, Journal article 2019
Journal article

Showing 1 - 10 of 429

Page Manager: Karin Allander|Last update: 10/1/2019
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?